Pharmacy benefit managers sit at the center of a four-way transaction between patients, insurers, drug manufacturers, and pharmacies. They’ve figured out how to skim profit from every single one of ...

Please provide your email address to receive an email when new articles are posted on . A federal spending package passed in February takes aim at pharmacy benefit managers. Experts discussed the ...

When 22-year-old Cole Schmidtknecht walked up to the pharmacy counter, he learned his Advair Diskus inhaler had jumped from under $70 to over $500. He walked away without the medicine. Within a week, ...

HOLLYWOOD, Fla., May 26, 2026 /PRNewswire/ -- With PBM reform moving from policy debate to active scrutiny, US-Rx Care says self-funded employers are facing a more demanding oversight environment even ...

Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution. They negotiate rebates, design formularies, adjudicate claims, and steer patient adherence. Modern artificial ...

“This is an exciting day as it represents our first analyst call reporting on our first ever quarter or, more accurately, partial quarter of sales since the commercial launch of CARDAMYST for acute ...

Optum Rx, UnitedHealth Group’s pharmacy benefit manager, said it will roll out a fee-based structure to customers in the coming years. A May 11 news release from Optum said Optum Rx’s agreements have ...

A twice-yearly shot could be the catalyst for stopping a recent spike in new HIV diagnoses that's disproportionately hitting young men of color, but the challenge is creating awareness among people ...

Years of debate and halting efforts to enact pharmacy benefit manager (PBM) reform came to a head in early 2026 with three independent but related federal actions, bringing with them substantial PBM ...

Earnings call Cigna reported FY25 adjusted revenue of $275B (+11% YoY) and adjusted EPS of $29.84 (+9% YoY), exceeding expectations. FY26 guidance includes revenue of ~$280B and EPS of at least $30.25 ...

WASHINGTON — Lawmakers on both sides of the aisle pressed health insurance CEOs on premium hikes, prior authorization rules and claim denials in back-to-back House committee hearings Thursday, zeroing ...